FAKTOR OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 12:26:56 2024-07-16 pm EDT | ||
| 2.96 EUR | +17.00% |
|
| Current month | +83.33% | ||
| 1 month | +201.19% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-16 | 2.96 | +17.00% |
| 24-07-15 | 2.53 | -15.38% |
| 24-07-12 | 2.99 | +28.33% |
| 24-07-11 | 2.33 | +27.32% |
| 24-07-10 | 1.83 | +35.56% |
Real-time BOERSE MUENCHEN
Last update July 16, 2024 at 12:26 pm EDT
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Goldman Sachs |
| WKN | GP40NY |
| ISIN | DE000GP40NY9 |
| Date issued | 2023-05-18 |
| Strike | 308.1 $ |
| Maturity | Unlimited |
| Parity | 7.64 : 1 |
| Emission price | 8.54 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 49.13 € |
|---|---|
| Lowest since issue | 0.56 € |
| Spread | 0.03 € |
| Spread % | 0.99% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
330.2
USD
Average target price
317.4
USD
Spread / Average Target
-3.86%
- Stock Market
- Certificates
- Certificat
